Geron Corp logo

Geron Corp

GERN
Healthcare|Biotechnology|USA
$1.50
-0.07 (-4.15%)
Tangible Book
$0.36

Analyst Estimates

annual
{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ 233.75, 333.14, 486.17, 697.46, 918.71 ], "ebit_estimate": [ -1.83, 39.12, 92.96, 371.49, 575.63 ], "ebitda_estimate": [ -8.49, -20.66, -11.07, null, null ], "net_income_estimate": [ -13.95, 47.9, 68.27, 234.57, 432.62 ], "per_share_eps_estimate": [ -0.02, 0.09, 0.25, 0.43, 0.64 ], "eps_nri_estimate": [ -0.02, 0.07, 0.19, 0.43, 0.64 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null ], "pretax_income_estimate": [ -19.06, 46.9, 150.58, 363.17, 573.18 ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null ], "gross_margin_estimate": [ 95.85, 96.3, 96.25, 96.5, 96.75 ], "operating_cash_flow_estimate": [ null, null, null, null, null ], "pettm_estimate": [ 0, 16.3, 5.93, 3.53, 2.34 ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "38.70", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": 38.7, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }
quarterly
{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712" ], "revenue_estimate": [ 55.21, 59.85, 66.82, 77.29, 84.61, 92.19, 99.69 ], "ebit_estimate": [ -1.41, -0.13, 2.17, 8.58, 14.02, 18.05, 20.84 ], "ebitda_estimate": [ -1.37, -4.14, -3.28, null, null, null, null ], "net_income_estimate": [ -4.33, -2.75, -0.25, 5.43, 10.87, 14.65, 16.59 ], "per_share_eps_estimate": [ -0.01, 0, 0, 0.02, 0.03, 0.04, 0.04 ], "eps_nri_estimate": [ -0.01, -0.01, 0, 0.02, 0.03, 0.04, 0.04 ], "dividend_estimate": [ null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null ], "pretax_income_estimate": [ -4.06, -2.72, -0.61, 3.2, 7.7, 12.4, 11.7 ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null, null, null ], "gross_margin_estimate": [ 95.9, 95.85, 95.3, 95, 95, 95, 97 ], "operating_cash_flow_estimate": [ null, null, null, null, null, null, null ], "pettm_estimate": [ 214.29, 35.71, 18.52, 12.1, null, null, null ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "38.70", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": 38.7, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }